Entities / Company
Zimmer Biomet Holdings.
medical device company
- Reports this week
- 0
- Active events
- 0
- Connections
- 83
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Zimmer Biomet Holdings is leveraging clinical expertise to influence its product pipeline and challenge the core orthopedics and robotics market.Well supported4 reports5 developments inside
-
Gary Campbell was promoted to President, Americas, and Kessler was promoted to President, Americas – Robotics.Some support1 report
-
Zimmer Biomet Holdings is donating its current headquarters building to Goshen College.Some support3 reports
One to three months ago
Gone quiet
No new reports in 90+ days-
Pacira BioSciences divested its iovera business unit to Zimmer Biomet Holdings.Some support1 report
-
The FDA granted clearance for a nerve ablation system from NeuroOne Medical Technologies, which has a distribution agreement with Zimmer Biomet.Well supported3 reports1 development inside
-
Zimmer Biomet plans to acquire Monogram for $177 million.Some support1 report
-
Zimmer Biomet is headquartered in Warsaw.Some support2 reports
-
Zimmer Biomet has a stronger earnings outlook compared to EssilorLuxottica.Some support1 report
-
Zimmer Biomet announces advancements in its product portfolio, including the ROSA Robotic Platform, Persona OsseoTi, and Oxford Partial Cementless Knee.Some support2 reports
-
Zacks Earnings ESP compared estimates to actual results for Zimmer Biomet on July 31, 2025.Some support1 report
-
Financial analysts and investors questioned Zimmer Biomet regarding pricing trends, growth translation, and product integration.Speculative1 report
-
Zimmer Biomet stock fell while the S&P 500 climbed on July 22, 2025.Some support1 report
-
Evercore ISI adjusted its price target for Zimmer Biomet on July 9, 2025.Speculative1 report
-
Zimmer Biomet and Smith & Nephew were highlighted as strong medical products stocks on September 3, 2025.Some support1 report
-
Stryker's strong sales are threatening Zimmer Biomet's market share in the medical device sector.Some support1 report
-
Goldman Sachs inquired about orthopedic market trends in August 2025.Some support2 reports1 development inside
-
Matson maintained a neutral stance on Zimmer Biomet Holdings stock, noting the influence of ZBH's acquisition strategy on analyst outlook.Some support1 report
-
Zimmer Biomet Holdings reported generating $1.17 billion in sales on August 7, 2025.Some support1 report
-
Zimmer Biomet Holdings acquired Monogram Technologies to expand its robotics suite.Well supported8 reports
-
Both Zimmer Biomet Holdings and Solventum raised their profit forecasts on August 8, 2025.Some support1 report
-
Zimmer Biomet Holdings stock underperformed the broader market on August 18, 2025.Some support3 reports
-
KLS Martin Group and Zimmer Biomet Holdings are identified as leading players in the biotech market.Some support1 report
-
Zimmer Biomet Holdings presented at a conference hosted by Morgan Stanley on August 25, 2025.Some support1 report
-
Paragon 28 is a wholly owned subsidiary of Zimmer Biomet Holdings.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Zimmer Biomet Holdings this week
News at the entities that move Zimmer Biomet Holdings most-
Goldman Sachs Mentioned togetherGoldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Moves Zimmer Biomet Holdings
-
Medtech Shared contextAlkem Laboratories built its MedTech business from the ground up and its board thanked the CFO for strategic mandates.Moves Zimmer Biomet Holdings
-
Indiana Shared contextA new agricultural strategy initiative in Indiana was developed in partnership with the Indiana Economic Development Association and supported by Duke Energy.Moves Zimmer Biomet Holdings
-
Warsaw Shared contextForesight is expanding its presence and investing in a data center project in Warsaw, Poland.Moves Zimmer Biomet Holdings
Connections
The 10 strongest of 83, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Gary Campbell Structural
Gary Campbell serves as President of the Americas for Zimmer Biomet Holdings.
-
Monogram Technologies (Slovakia) Structural
Zimmer Biomet successfully acquired Monogram Technologies and is integrating its specialized orthopaedic robotics technology into its core business operations.
-
Kessler Structural
Kessler holds a high-level executive position (President, Americas – Robotics) within Zimmer Biomet Holdings.
-
Baxter International Operational
Both companies operate as peers within the competitive healthcare equipment market.
-
Michael Matson Mentioned together
Zimmer Biomet's strategy is subject to analyst outlook, which includes Michael Matson's commentary.
-
Goldman Sachs Mentioned together
Goldman Sachs analysts track Zimmer Biomet's performance, and the company presents at the bank's conferences.
-
Medtech Shared context
The company is strategically positioned and aims to be a leading entity within the MedTech sector.
-
Goshen College Transactional
Zimmer Biomet Holdings is donating its current headquarters building to Goshen College.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
1 eventJune 2026
22 events- Zimmer Biomet Holdings is leveraging clinical expertise to influence its product pipeline and challenge the core orthopedics and robotics market.
- Pacira BioSciences divested its iovera business unit to Zimmer Biomet Holdings.
- The FDA granted clearance for a nerve ablation system from NeuroOne Medical Technologies, which has a distribution agreement with Zimmer Biomet.
- Zimmer Biomet plans to acquire Monogram for $177 million.
- Zimmer Biomet is headquartered in Warsaw.
- Zimmer Biomet has a stronger earnings outlook compared to EssilorLuxottica.
- Zimmer Biomet announces advancements in its product portfolio, including the ROSA Robotic Platform, Persona OsseoTi, and Oxford Partial Cementless Knee.
- Zacks Earnings ESP compared estimates to actual results for Zimmer Biomet on July 31, 2025.
- Financial analysts and investors questioned Zimmer Biomet regarding pricing trends, growth translation, and product integration.
- Zimmer Biomet stock fell while the S&P 500 climbed on July 22, 2025.
- Evercore ISI adjusted its price target for Zimmer Biomet on July 9, 2025.
- Zimmer Biomet and Smith & Nephew were highlighted as strong medical products stocks on September 3, 2025.
- Stryker's strong sales are threatening Zimmer Biomet's market share in the medical device sector.
- Goldman Sachs inquired about orthopedic market trends in August 2025.
- Matson maintained a neutral stance on Zimmer Biomet Holdings stock, noting the influence of ZBH's acquisition strategy on analyst outlook.
- Zimmer Biomet Holdings reported generating $1.17 billion in sales on August 7, 2025.
- Zimmer Biomet Holdings acquired Monogram Technologies to expand its robotics suite.
- Both Zimmer Biomet Holdings and Solventum raised their profit forecasts on August 8, 2025.
- Zimmer Biomet Holdings stock underperformed the broader market on August 18, 2025.
- KLS Martin Group and Zimmer Biomet Holdings are identified as leading players in the biotech market.
- Zimmer Biomet Holdings presented at a conference hosted by Morgan Stanley on August 25, 2025.
- Paragon 28 is a wholly owned subsidiary of Zimmer Biomet Holdings.